de
Performance
Key Figures
Financial Reports
Share Buyback Programme
Press Releases
Securities
Management Transactions
Disclosure of Shareholdings
Company Presentation
Calendar
FAQ
News Registration
Contact
News Registration
Yes, I would like to receive news by email.
Title
Mr
Mrs
First name*
Last name*
Company
Email*
Phone
Address
Code
City
Country*
Please fill in this code*
*mandatory
You can
unsubscribe
at any time.
For sending us a message, please use the
contact form
.
News
Press Releases
»
Disclosure of shareholdings according to articles 9 and 21 of the Stock Exchange Ordinance of the Swiss Financial Market Supervisory Authority FINMA
»
ChemoCentryx receives an option payment of USD 35 million from GlaxoSmithKline for a licensing agreement
»
Major financing round for PTC Therapeutics at 2.2 times the previous valuation
»
Archive
Financial Reports
»
Quarterly Report December 2009
»
Archive
Share Price
SIX Swiss Exchange Ticker
HBMN
Key Figures
as at 28.02.2010
CHF
NAV
per share
68.38
Net assets
693 Mio.
Search
News Registration
Sign up now